Wegovy 2.4 mg (Semaglutide 2.4 mg per dose) by Novo Nordisk.
Indications: Adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with BMI ≥30 kg/m², or ≥27 kg/m² with at least one weight-related comorbidity; also approved for adolescents 12+ with obesity and for cardiovascular risk reduction.
Administration: Subcutaneous injection once weekly. 2.4 mg is the target maintenance dose.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. May be kept below 30 °C for up to 28 days.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Novo Nordisk |
| Active ingredient | Semaglutide 2.4 mg per dose (GLP-1 receptor agonist). |
| Strength & pack | Single-dose pre-filled pens (4 pens = 4 weekly doses) or FlexTouch multi-dose pen, depending on market. |
| Form | Solution for injection in a pre-filled pen |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. May be kept below 30 °C for up to 28 days. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |